Gene · 9049
NIH grants1,062
NIH grants whose papers are about the gene, through NIH's grant-paper links.
281 to 300 of 1,062
Download this page as JSON| Grant | Title | AIP papers | Newest fiscal year |
|---|---|---|---|
| R01GM127675 | Determinants of the Hsp90-client interaction | 2 | 2022 |
| R35GM118099 | Structure and Mechanism: Hsp90 proteostasis, cilia biogenesis and the jumbo phage “nucleus” | 2 | 2022 |
| T32CA009685 | Head and Neck Training Program in Surgical Oncology | 2 | 2022 |
| T32DK007770 | Training Program in Endocrinology, Diabetes, and Metabolism | 2 | 2022 |
| I01RX002654 | Restoring High Dimensional Hand Function to Persons with Chronic High Tetraplegia | 1 | 2022 |
| K08HL140197 | Novel molecular therapies for CPVT | 1 | 2022 |
| K99NS124748 | Neural dynamics of somatosensory guidance of dexterous movement in intact and stroke-injured networks | 1 | 2022 |
| P01AI062885 | Epithelial innate signaling in airway inflammation and remodeling | 1 | 2022 |
| P01AI132132 | Zika virus pathophysiology during pregnancy | 1 | 2022 |
| R01AG056699 | Impact of Heightened UPR Activation on Inflammasome Responses to Influenza and Secondary Streptococcus pneumoniae Infection in Aged Lung | 1 | 2022 |
| R01AG061894 | Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease | 1 | 2022 |
| R01AI138647 | Assessing the impact of acquired immunodeficiency on congenital Zika virus | 1 | 2022 |
| R01AR073135 | 3D printed muscle-bone organ implant for treating large injuries | 1 | 2022 |
| R01AR073822 | Microengineered scaffolds carrying patient-specific cells and growth factors for treatment of volumetric muscle loss | 1 | 2022 |
| R01AR074234 | Oxygen generating bioinks for 3D printed bone implants | 1 | 2022 |
| R01CA219342 | ATR Isomerization in Cellular Responses to UV Damage of DNA | 1 | 2022 |
| R01CA227450 | Restoring genome stability and tumor suppression in BRCA1 deficient cells | 1 | 2022 |
| R01DK068306 | Novel genetics, pathobiology and therapy of nephronophthisis-related ciliopathies | 1 | 2022 |
| R01DK114345 | Protein Markers to Islet Autoimmunity and T1D Progression | 1 | 2022 |
| R01DK122586 | Functional Mechanisms of T1D Risk Variants and their Target Genes using 3D Epigenomics and Single Cell Approaches | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9049/grants?page=15